TVTX — Travere Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapNeutral

Annual balance sheet for Travere Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	553	450	567	371	323
Net Total Accounts Receivable
Net Total Receivables	16.2	16.6	21.2	27.1	80.1
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	583	486	617	417	438
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	34.3	30	25.5	19.6	14.6
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	777	673	789	594	605
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	124	142	178	201	160
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	475	630	588	535	490
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	302	42.9	201	59.1	115
Total Liabilities & Shareholders' Equity	777	673	789	594	605
Total Common Shares Outstanding